Saudi-based Sudair Pharma Company is set to establish its new insulin plant in the Sudair City for Industry and Businesses.

As Saudi Arabia moves toward healthcare self-sufficiency under Vision 2030, the localization of vital pharmaceutical manufacturing has become a critical priority. In a major step forward, Sanofi, ...

Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of ...

as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made ...

Speaking to an assembly of global leaders ... for Energy Security and Net Zero was not immediately available to comment. The CEO of French pharmaceutical giant Sanofi doubled down on plans to ...

GMG, a global retailer, manufacturer and distributor, has established itself as a dominant force in the retail industry ...

These ten new MoUs follow NUPCO’s recent agreements with global pharmaceutical leaders, including Novo Nordisk (Denmark) and ...

Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for ...

Additionally, FPT’s digital transformation solution for Long Chau Pharmacy has enhanced the customer experience by enabling ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...